Joel M. Topf, MD, FACP

Articles by Joel M. Topf, MD, FACP

Mohamed G. Atta, MD, MPHNephrology Times | July 25, 2024
Members of the Nephrology Times editorial board shared the nephrology research and news they’ve found most notable this ...
Read More
Cesia Portillo, MPHNKF Spring Clinical Meetings 2024 | June 4, 2024
Cesia Portillo discussed her poster on creating a roadmap for APOL1-mediated kidney disease (AMKD).
Suzanne Watnick, MDNKF Spring Clinical Meetings 2024 | June 3, 2024
Suzanne Watnick shared thoughts on the Shaul G. Massry lectureship, COVID-19, kidney transplantation, and policy issues.
Yasemin Balin, MDNKF Spring Clinical Meetings 2024 | June 3, 2024
A. Ersin Yassa and Yasemin Balin were the winners of the inaugural Neph Madness tournament.
Joel M. Topf, MD, FACPNKF Spring Clinical Meetings 2024 | May 31, 2024
Martin Pollak reflected on winning the David M. Hume Memorial Award and on breakthroughs in glomerular diseases.
Sylvia Rosas, MD, MSCENKF Spring Clinical Meetings 2024 | May 31, 2024
Sylvia Rosas shared highlights from her term as president of the National Kidney Foundation.
Areef Ishani, MDNKF Spring Clinical Meetings 2024 | May 30, 2024
Areef Ishani spoke about his abstract on renal outcomes with chlorthalidone versus hydrochlorothiazide for hypertension.
Joel M. Topf, MD, FACPNKF Spring Clinical Meetings 2024 | May 24, 2024
Editorial board member Joel Topf reflects on the NKF Spring Clinical Meetings and the value of #NephTwitter.
Robert Montgomery, MD, PhDNKF Spring Clinical Meetings 2024 | May 29, 2024
Dr. Robert Montgomery spoke about advances in xenotransplantation, including the pig kidney transplant he recently performed.
Dana V. Rizk, MDNKF Spring Clinical Meetings 2024 | May 29, 2024
Dr. Dana Rizk discussed her APPLAUSE-IgAN study findings on iptacopan versus placebo for IgA nephropathy.
Joel M. Topf, MD, FACPChronic Kidney Disease | April 3, 2024
Vlado Perkovic has not presented the results of the FLOW trial, but the surprise is gone. We know what he is going to say.